The diabetes care devices market size has grown rapidly in recent years. It will grow from $73.91 billion in 2025 to $82.22 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to rising global diabetes prevalence, improved access to glucose monitoring devices, expansion of outpatient diabetes care, increased awareness of self-monitoring practices, growing availability of disposable testing supplies.
The diabetes care devices market size is expected to see rapid growth in the next few years. It will grow to $130.76 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing demand for real-time glucose monitoring, rising adoption of closed-loop insulin systems, expansion of digital diabetes management platforms, growing focus on personalized diabetes care, increasing healthcare investments in chronic disease management. Major trends in the forecast period include increasing adoption of continuous glucose monitoring devices, rising use of smart insulin delivery systems, growing integration of mobile health platforms, expansion of connected diabetes management ecosystems, enhanced focus on patient-centric monitoring solutions.
Rising healthcare expenditures are expected to drive the growth of the diabetes care device market in the future. Healthcare expenditures refer to the total amount spent on healthcare services, products, and activities over a specific period, typically measured at the individual, community, national, or global level. The combination of increasing healthcare expenditures, improved access to healthcare services, and a rise in diabetes diagnoses contributes to higher investments in research and development. This, in turn, leads to advancements in diabetes care devices, including enhanced glucose monitoring systems, insulin delivery devices, and digital health solutions. For example, in June 2025, the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, reported that National Health Expenditure (NHE) increased by 7.5% to $4.9 trillion in 2023, equal to $14,570 per capita, and represented 17.6% of Gross Domestic Product (GDP). During the same year, hospital spending rose by 10.4% to $1.51 trillion, accelerating from the 3.2% growth recorded in 2022. Therefore, the increase in healthcare expenditure is poised to fuel the growth of the diabetes care device market in the coming years.
Major companies operating in the diabetes care devices market are concentrating on the development of advanced solutions such as real-time glucose monitoring technology to improve accuracy, ease of use, and proactive disease management. Real-time glucose monitoring technology delivers continuous, automatic glucose readings and alerts, enabling people with diabetes to make timely decisions and lower health risks. For example, in August 2025, Abbott Laboratories, a US-based healthcare company, introduced the FreeStyle Libre 2 Plus, which provides minute-by-minute glucose readings directly to a compatible smartphone and includes optional alerts for high and low glucose levels. The device supports effective diabetes self-management by offering automatic notifications, historical data, and trend arrows without the need for routine fingerstick testing. It operates using near-field communication and Bluetooth connectivity, can be worn for up to 15 days, and allows caregivers to receive glucose information through connected digital health platforms. Overall, the device enhances patient safety by enabling rapid intervention and improves user engagement through real-time health insights that support everyday decision-making.
In September 2025, Glooko Inc., a US-based provider of remote patient monitoring platforms, digital diabetes management solutions, and connected device integration tools, acquired Monarch Medical Technologies for an undisclosed amount. Through this acquisition, Glooko plans to extend its connected diabetes care ecosystem into inpatient environments by integrating Monarch’s insulin-dosing technology to establish a unified hospital-to-home glycemic management platform. Monarch Medical Technologies, a US-based company, supplies FDA-cleared inpatient glucose management software, including the EndoTool system designed to support precise, algorithm-based insulin dosing in hospital settings.
Major companies operating in the diabetes care devices market are Abbott Laboratories, Becton Dickinson and Company, Roche Holding AG, Medtronic plc, Dexcom Inc., Novo Nordisk A/S, Eli Lilly and Company, LifeScan Inc., Ascensia Diabetes Care, Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation, Nipro Corporation, Owen Mumford Ltd., ARKRAY Inc., AgaMatrix Inc., Acon Laboratories Inc., HTL-STREFA S.A., Sanofi India Limited.
North America was the largest region in the global diabetes care devices market in 2025. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the diabetes care devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are influencing the diabetes care devices market by increasing costs of imported sensors, semiconductors, microelectronics, plastic disposables, and medical-grade components used in glucose meters, CGM systems, and insulin pumps. Healthcare providers and device manufacturers in North America and Europe are most affected due to reliance on cross-border component sourcing, while Asia-Pacific faces higher costs in device assembly and exports. These tariffs are contributing to higher device prices and reimbursement pressures. However, they are also driving domestic manufacturing, localized supply chains, and innovation in cost-efficient diabetes monitoring and delivery solutions.
The diabetes care devices market research report is one of a series of new reports that provides diabetes care devices market statistics, including diabetes care devices industry global market size, regional shares, competitors with a diabetes care devices market share, detailed diabetes care devices market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes care devices industry. This diabetes care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Diabetes care devices are employed to monitor and manage blood glucose levels in individuals with diabetes.
The primary categories of diabetes care devices include blood glucose test strips, insulin pens, syringes, pumps and injectors, lancing devices and equipment, continuous glucose monitoring devices and equipment, and blood glucose meters. Insulin pens are devices equipped with a needle to administer insulin into the subcutaneous tissue. Expenditures can be classified as public or private, and the products utilized fall into the categories of instruments/equipment and disposables. Testing methods encompass both point-of-care (POC) testing and non-point-of-care (POC) testing, with diverse end-users, including hospitals and clinics, diagnostic laboratories, and others.
The diabetes care devices market consists of sales of blood glucose monitoring devices, insulin delivery devices, smart insulin pens and others that are used for monitor and treat diabetes patient. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The diabetes care devices market size is expected to see rapid growth in the next few years. It will grow to $130.76 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing demand for real-time glucose monitoring, rising adoption of closed-loop insulin systems, expansion of digital diabetes management platforms, growing focus on personalized diabetes care, increasing healthcare investments in chronic disease management. Major trends in the forecast period include increasing adoption of continuous glucose monitoring devices, rising use of smart insulin delivery systems, growing integration of mobile health platforms, expansion of connected diabetes management ecosystems, enhanced focus on patient-centric monitoring solutions.
Rising healthcare expenditures are expected to drive the growth of the diabetes care device market in the future. Healthcare expenditures refer to the total amount spent on healthcare services, products, and activities over a specific period, typically measured at the individual, community, national, or global level. The combination of increasing healthcare expenditures, improved access to healthcare services, and a rise in diabetes diagnoses contributes to higher investments in research and development. This, in turn, leads to advancements in diabetes care devices, including enhanced glucose monitoring systems, insulin delivery devices, and digital health solutions. For example, in June 2025, the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, reported that National Health Expenditure (NHE) increased by 7.5% to $4.9 trillion in 2023, equal to $14,570 per capita, and represented 17.6% of Gross Domestic Product (GDP). During the same year, hospital spending rose by 10.4% to $1.51 trillion, accelerating from the 3.2% growth recorded in 2022. Therefore, the increase in healthcare expenditure is poised to fuel the growth of the diabetes care device market in the coming years.
Major companies operating in the diabetes care devices market are concentrating on the development of advanced solutions such as real-time glucose monitoring technology to improve accuracy, ease of use, and proactive disease management. Real-time glucose monitoring technology delivers continuous, automatic glucose readings and alerts, enabling people with diabetes to make timely decisions and lower health risks. For example, in August 2025, Abbott Laboratories, a US-based healthcare company, introduced the FreeStyle Libre 2 Plus, which provides minute-by-minute glucose readings directly to a compatible smartphone and includes optional alerts for high and low glucose levels. The device supports effective diabetes self-management by offering automatic notifications, historical data, and trend arrows without the need for routine fingerstick testing. It operates using near-field communication and Bluetooth connectivity, can be worn for up to 15 days, and allows caregivers to receive glucose information through connected digital health platforms. Overall, the device enhances patient safety by enabling rapid intervention and improves user engagement through real-time health insights that support everyday decision-making.
In September 2025, Glooko Inc., a US-based provider of remote patient monitoring platforms, digital diabetes management solutions, and connected device integration tools, acquired Monarch Medical Technologies for an undisclosed amount. Through this acquisition, Glooko plans to extend its connected diabetes care ecosystem into inpatient environments by integrating Monarch’s insulin-dosing technology to establish a unified hospital-to-home glycemic management platform. Monarch Medical Technologies, a US-based company, supplies FDA-cleared inpatient glucose management software, including the EndoTool system designed to support precise, algorithm-based insulin dosing in hospital settings.
Major companies operating in the diabetes care devices market are Abbott Laboratories, Becton Dickinson and Company, Roche Holding AG, Medtronic plc, Dexcom Inc., Novo Nordisk A/S, Eli Lilly and Company, LifeScan Inc., Ascensia Diabetes Care, Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation, Nipro Corporation, Owen Mumford Ltd., ARKRAY Inc., AgaMatrix Inc., Acon Laboratories Inc., HTL-STREFA S.A., Sanofi India Limited.
North America was the largest region in the global diabetes care devices market in 2025. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the diabetes care devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are influencing the diabetes care devices market by increasing costs of imported sensors, semiconductors, microelectronics, plastic disposables, and medical-grade components used in glucose meters, CGM systems, and insulin pumps. Healthcare providers and device manufacturers in North America and Europe are most affected due to reliance on cross-border component sourcing, while Asia-Pacific faces higher costs in device assembly and exports. These tariffs are contributing to higher device prices and reimbursement pressures. However, they are also driving domestic manufacturing, localized supply chains, and innovation in cost-efficient diabetes monitoring and delivery solutions.
The diabetes care devices market research report is one of a series of new reports that provides diabetes care devices market statistics, including diabetes care devices industry global market size, regional shares, competitors with a diabetes care devices market share, detailed diabetes care devices market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes care devices industry. This diabetes care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Diabetes care devices are employed to monitor and manage blood glucose levels in individuals with diabetes.
The primary categories of diabetes care devices include blood glucose test strips, insulin pens, syringes, pumps and injectors, lancing devices and equipment, continuous glucose monitoring devices and equipment, and blood glucose meters. Insulin pens are devices equipped with a needle to administer insulin into the subcutaneous tissue. Expenditures can be classified as public or private, and the products utilized fall into the categories of instruments/equipment and disposables. Testing methods encompass both point-of-care (POC) testing and non-point-of-care (POC) testing, with diverse end-users, including hospitals and clinics, diagnostic laboratories, and others.
The diabetes care devices market consists of sales of blood glucose monitoring devices, insulin delivery devices, smart insulin pens and others that are used for monitor and treat diabetes patient. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Diabetes Care Devices Market Characteristics
3. Diabetes Care Devices Market Supply Chain Analysis
4. Global Diabetes Care Devices Market Trends and Strategies
5. Diabetes Care Devices Market Analysis of End Use Industries
7. Global Diabetes Care Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Diabetes Care Devices Total Addressable Market (TAM) Analysis for the Market
9. Diabetes Care Devices Market Segmentation
10. Diabetes Care Devices Market Regional and Country Analysis
11. Asia-Pacific Diabetes Care Devices Market
12. China Diabetes Care Devices Market
13. India Diabetes Care Devices Market
14. Japan Diabetes Care Devices Market
15. Australia Diabetes Care Devices Market
16. Indonesia Diabetes Care Devices Market
17. South Korea Diabetes Care Devices Market
18. Bangladesh Diabetes Care Devices Market
19. Thailand Diabetes Care Devices Market
20. Vietnam Diabetes Care Devices Market
21. Malaysia Diabetes Care Devices Market
22. Singapore Diabetes Care Devices Market
23. Philippines Diabetes Care Devices Market
24. Hong Kong Diabetes Care Devices Market
25. New Zealand Diabetes Care Devices Market
26. Taiwan Diabetes Care Devices Market
27. South East Asia Diabetes Care Devices Market
28. Western Europe Diabetes Care Devices Market
29. UK Diabetes Care Devices Market
30. Germany Diabetes Care Devices Market
31. France Diabetes Care Devices Market
32. Italy Diabetes Care Devices Market
33. Spain Diabetes Care Devices Market
34. Austria Diabetes Care Devices Market
35. Belgium Diabetes Care Devices Market
36. Denmark Diabetes Care Devices Market
37. Finland Diabetes Care Devices Market
38. Ireland Diabetes Care Devices Market
39. Netherlands Diabetes Care Devices Market
40. Norway Diabetes Care Devices Market
41. Portugal Diabetes Care Devices Market
42. Sweden Diabetes Care Devices Market
42. Switzerland Diabetes Care Devices Market
43. Eastern Europe Diabetes Care Devices Market
44. Russia Diabetes Care Devices Market
45. Czech Republic Diabetes Care Devices Market
46. Poland Diabetes Care Devices Market
47. Romania Diabetes Care Devices Market
48. Ukraine Diabetes Care Devices Market
49. North America Diabetes Care Devices Market
50. USA Diabetes Care Devices Market
51. Canada Diabetes Care Devices Market
52. Mexico Diabetes Care Devices Market
53. South America Diabetes Care Devices Market
54. Brazil Diabetes Care Devices Market
55. Chile Diabetes Care Devices Market
56. Argentina Diabetes Care Devices Market
57. Colombia Diabetes Care Devices Market
58. Peru Diabetes Care Devices Market
59. Middle East Diabetes Care Devices Market
60. Saudi Arabia Diabetes Care Devices Market
61. Israel Diabetes Care Devices Market
62. Iran Diabetes Care Devices Market
63. Turkey Diabetes Care Devices Market
64. United Arab Emirates Diabetes Care Devices Market
65. Africa Diabetes Care Devices Market
66. Egypt Diabetes Care Devices Market
67. Nigeria Diabetes Care Devices Market
68. South Africa Diabetes Care Devices Market
70. Diabetes Care Devices Market Competitive Landscape and Company Profiles
71. Diabetes Care Devices Market Other Major and Innovative Companies
74. Diabetes Care Devices Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Diabetes Care Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses diabetes care devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for diabetes care devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetes care devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Blood Glucose Test Strips; Insulin Pens; Syringes; Pumps And Injectors; Lancing Devices And Equipment; Continuous Glucose Monitoring Devices And Equipment; Blood Glucose Meters2) By Type of Expenditure: Public; Private
3) By Consumable Type: Instruments Or Equipment; Disposables
4) By Type Of Testing: Point Of Care (POC) Testing; Non-Point Of Care (POC) Testing
5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Blood Glucose Test Strips: Standard Blood Glucose Test Strips; Test Strips for Continuous Glucose Monitors2) By Insulin Pens: Pre-filled Insulin Pens; Reusable Insulin Pens; Smart Insulin Pens
3) By Syringes: Insulin Syringes (various capacities); Disposable Syringes; Safety Syringes
4) By Pumps and Injectors: Insulin Pumps; Insulin Jet Injectors; Patch Pumps
5) By Lancing Devices and Equipment: Manual Lancing Devices; Automatic Lancing Devices; Lancets (various gauges)
6) By Continuous Glucose Monitoring Devices and Equipment: Real-Time CGM Systems; Flash Glucose Monitoring Systems; CGM Sensors and Transmitters
7) By Blood Glucose Meters: Standard Blood Glucose Meters; Smart Blood Glucose Meters; Meters with Integrated Data Management
Companies Mentioned: Abbott Laboratories; Becton Dickinson and Company; Roche Holding AG; Medtronic plc; Dexcom Inc.; Novo Nordisk A/S; Eli Lilly and Company; LifeScan Inc.; Ascensia Diabetes Care; Tandem Diabetes Care Inc.; Insulet Corporation; Ypsomed AG; Terumo Corporation; Nipro Corporation; Owen Mumford Ltd.; ARKRAY Inc.; AgaMatrix Inc.; Acon Laboratories Inc.; HTL-STREFA S.A.; Sanofi India Limited
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Diabetes Care Devices market report include:- Abbott Laboratories
- Becton Dickinson and Company
- Roche Holding AG
- Medtronic plc
- Dexcom Inc.
- Novo Nordisk A/S
- Eli Lilly and Company
- LifeScan Inc.
- Ascensia Diabetes Care
- Tandem Diabetes Care Inc.
- Insulet Corporation
- Ypsomed AG
- Terumo Corporation
- Nipro Corporation
- Owen Mumford Ltd.
- ARKRAY Inc.
- AgaMatrix Inc.
- Acon Laboratories Inc.
- HTL-STREFA S.A.
- Sanofi India Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 82.22 Billion |
| Forecasted Market Value ( USD | $ 130.76 Billion |
| Compound Annual Growth Rate | 12.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
